1. Home
  2. CORT vs PII Comparison

CORT vs PII Comparison

Compare CORT & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • PII
  • Stock Information
  • Founded
  • CORT 1998
  • PII 1954
  • Country
  • CORT United States
  • PII United States
  • Employees
  • CORT N/A
  • PII N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • PII Recreational Games/Products/Toys
  • Sector
  • CORT Health Care
  • PII Consumer Discretionary
  • Exchange
  • CORT Nasdaq
  • PII Nasdaq
  • Market Cap
  • CORT 4.0B
  • PII 3.8B
  • IPO Year
  • CORT N/A
  • PII 1987
  • Fundamental
  • Price
  • CORT $55.92
  • PII $66.96
  • Analyst Decision
  • CORT Strong Buy
  • PII Buy
  • Analyst Count
  • CORT 4
  • PII 12
  • Target Price
  • CORT $75.25
  • PII $85.00
  • AVG Volume (30 Days)
  • CORT 1.1M
  • PII 675.2K
  • Earning Date
  • CORT 10-30-2024
  • PII 10-22-2024
  • Dividend Yield
  • CORT N/A
  • PII 3.96%
  • EPS Growth
  • CORT 57.97
  • PII N/A
  • EPS
  • CORT 1.26
  • PII 3.57
  • Revenue
  • CORT $628,555,000.00
  • PII $7,803,200,000.00
  • Revenue This Year
  • CORT $46.29
  • PII N/A
  • Revenue Next Year
  • CORT $17.09
  • PII $1.03
  • P/E Ratio
  • CORT $44.35
  • PII $18.75
  • Revenue Growth
  • CORT 39.67
  • PII N/A
  • 52 Week Low
  • CORT $20.84
  • PII $64.56
  • 52 Week High
  • CORT $61.66
  • PII $100.91
  • Technical
  • Relative Strength Index (RSI)
  • CORT 61.47
  • PII 36.02
  • Support Level
  • CORT $51.51
  • PII $64.56
  • Resistance Level
  • CORT $61.66
  • PII $68.59
  • Average True Range (ATR)
  • CORT 2.82
  • PII 1.79
  • MACD
  • CORT -0.22
  • PII 0.06
  • Stochastic Oscillator
  • CORT 59.09
  • PII 25.89

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, including motorcycles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to another segment of the outdoor lifestyle market. Polaris products retailed through more than 2,500 dealers in North America and through 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

Share on Social Networks: